EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Edwards Lifesciences (EW) tumbles as guidance misses expectations
October 26, 2023 10:07 AM EDTEdwards Lifesciences (NYSE: EW) shares tumbled over 8% in after-hours trading after the company's latest earnings and guidance announcement disappointed investors and analysts alike.
After Wednesday's close, the company reported Q3 earnings of $0.59 per share, in line with the analyst estimate of $0.59. Revenue for the quarter was also in line, coming in at $1.48 billion, although that was a 12%... More
Edwards Lifesciences (EW) Reports In-Line Q3 EPS
October 25, 2023 4:16 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.
GUIDANCE:
Edwards Lifesciences sees Q4 2023 revenue of $1.45-1.53 billion, versus the consensus of... More
